Product features

Indications

ALLEVYN LIFE Quadrilobe Application

Customer information

Disclaimer

*n=37; dressing retention was 1.92x longer.

**In a pragmatic, randomized, controlled, superiority trial. p=0.001; n=359. Estimated cost savings vs standard preventive care alone; n=359.

***Compared to previous dressings. Ambispective (retrospective and prospective) observational study. 1.66 ALLEVYN LIFE Dressings per week vs 3.14 previous dressings (foams or gelling fibres); n=94; p<0.001). €11.46 ALLEVYN LIFE Dressings vs €27.75 previous dressings (foams or gelling fibres); n=94; p<0.001).

****n=38. Time saving based on previous dressing, estimated for 169 patients requiring ≥3 visits per week.

Please see Instructions for Use (IFU) for indications, contraindications, warnings, precautions and other important information.

Recall and Complaints

Customer will provide such support and assistance as S+N may reasonably request in the event of a general or limited voluntary or mandatory recall of the Product(s). Customer shall promptly report any complaint in respect of the Products to complaints@smith-nephew.com.

Terms & Conditions and Warranties

Citations

1. Milne J, et al. J Wound Care. 2020;29(5):282-288.

2. Lindholm C, et al. Int Wound J. 2016;13 Suppl 2:5-15.

3. Stankiewicz M, et al. WP&R Journal. 2019;27(1):21 – 26

4. Smith+Nephew 2018. Internal report. DS/18/351/R.

5. Forni C, et al. Int Wound J. 2018; 15(3):383-390.

6. Forni C, et al. J Wound Care. 2020;29(2):120 - 127.

7. Joy H, et al. J Wound Care. 2015 Jul;24(7):312, 314-7.

8. Smith+Nephew 2018. Internal report. HVT080A 970A.

9. Simon D, et al. Wounds UK. 2014;10(3):80-87.

10. Rossington A, et al. Wounds UK. 2013;9(4):91-95.

11. Krönert GT, et al. EWMA Journal. 2016;16(2):7-12.

12. Stephen-Haynes J, et al. Journal of Community Nursing. 2013;27(5):50-59.

13. Tiscar-Gonzalez V, et al. Adv Skin Wound Care. 2021;34(1):23–30.

Title

Text